These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14515344)

  • 1. Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA.
    Brodie JD; Figueroa E; Dewey SL
    Synapse; 2003 Dec; 50(3):261-5. PubMed ID: 14515344
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.
    Brodie JD; Figueroa E; Laska EM; Dewey SL
    Synapse; 2005 Feb; 55(2):122-5. PubMed ID: 15543630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results.
    Fechtner RD; Khouri AS; Figueroa E; Ramirez M; Federico M; Dewey SL; Brodie JD
    Arch Ophthalmol; 2006 Sep; 124(9):1257-62. PubMed ID: 16966620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.
    Somoza EC; Winship D; Gorodetzky CW; Lewis D; Ciraulo DA; Galloway GP; Segal SD; Sheehan M; Roache JD; Bickel WK; Jasinski D; Watson DW; Miller SR; Somoza P; Winhusen T
    JAMA Psychiatry; 2013 Jun; 70(6):630-7. PubMed ID: 23575810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual field and ocular safety during short-term vigabatrin treatment in cocaine abusers.
    Berezina TL; Khouri AS; Winship MD; Fechtner RD
    Am J Ophthalmol; 2012 Aug; 154(2):326-332.e2. PubMed ID: 22704138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine withdrawal symptoms predict medication response in cocaine users.
    Sofuoglu M; Poling J; Gonzalez G; Gonsai K; Kosten T
    Am J Drug Alcohol Abuse; 2006; 32(4):617-27. PubMed ID: 17127550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Succinic semialdehyde dehydrogenase deficiency: decrease in 4-OH-butyric acid levels with low doses of vigabatrin].
    Escalera GI; Ferrer I; Marina LC; Sala PR; Salomons GS; Jakobs C; Pérez-Cerdá C
    An Pediatr (Barc); 2010 Feb; 72(2):128-32. PubMed ID: 20018576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential value of a negative finding: an illustrative example.
    Silverman K; DeFulio A; Leoutsakos JM
    JAMA Psychiatry; 2013 Jun; 70(6):571-2. PubMed ID: 23575653
    [No Abstract]   [Full Text] [Related]  

  • 9. New medications for the treatment of cocaine dependence.
    Kampman KM
    Ann Ist Super Sanita; 2009; 45(2):109-15. PubMed ID: 19636162
    [No Abstract]   [Full Text] [Related]  

  • 10. Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency.
    Leuzzi V; Di Sabato ML; Deodato F; Rizzo C; Boenzi S; Carducci C; Malaspina P; Liberanome C; Dionisi-Vici C
    Neurology; 2007 Apr; 68(16):1320-1. PubMed ID: 17438226
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat.
    Stromberg MF; Mackler SA; Volpicelli JR; O'Brien CP; Dewey SL
    Pharmacol Biochem Behav; 2001 Feb; 68(2):291-9. PubMed ID: 11267634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction.
    Roberts DC
    Physiol Behav; 2005 Sep; 86(1-2):18-20. PubMed ID: 16061264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding treatment options for cocaine dependence.
    Brady KT
    Am J Psychiatry; 2009 Nov; 166(11):1209-10. PubMed ID: 19884233
    [No Abstract]   [Full Text] [Related]  

  • 14. New treatments for cocaine dependence: a focused review.
    Karila L; Gorelick D; Weinstein A; Noble F; Benyamina A; Coscas S; Blecha L; Lowenstein W; Martinot JL; Reynaud M; Lépine JP
    Int J Neuropsychopharmacol; 2008 May; 11(3):425-38. PubMed ID: 17927843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency.
    Ergezinger K; Jeschke R; Frauendienst-Egger G; Korall H; Gibson KM; Schuster VH
    Ann Neurol; 2003 Nov; 54(5):686-9. PubMed ID: 14595661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.
    Winhusen T; Somoza E; Sarid-Segal O; Goldsmith RJ; Harrer JM; Coleman FS; Kahn R; Osman S; Mezinskis J; Li SH; Lewis D; Afshar M; Ciraulo DA; Horn P; Montgomery MA; Elkashef A
    Drug Alcohol Depend; 2007 Dec; 91(2-3):205-12. PubMed ID: 17628352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram: old addiction drug gains new support.
    Stezhka T
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):101. PubMed ID: 23593718
    [No Abstract]   [Full Text] [Related]  

  • 18. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study.
    Mardikian PN; LaRowe SD; Hedden S; Kalivas PW; Malcolm RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):389-94. PubMed ID: 17113207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
    Winhusen T; Somoza E; Ciraulo DA; Harrer JM; Goldsmith RJ; Grabowski J; Coleman FS; Mindrum G; Kahn R; Osman S; Mezinskis J; Li SH; Lewis D; Horn P; Montgomery MA; Elkashef A
    Drug Alcohol Depend; 2007 Dec; 91(2-3):141-8. PubMed ID: 17629631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin efficacy in GPR56-associated polymicrogyria: The role of GABAA receptor pathway.
    Bellusci M; Trivisano M; de Palma L; Pietrafusa N; Vigevano F; Specchio N
    Epilepsia; 2016 Aug; 57(8):1337-8. PubMed ID: 27485378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.